Research Focus: Biomarcatori, Caratterizzazione molecolare, Comunicazione intercellulare
Regione: Basilicata
Matrici: Plasma/siero
Strumentazione: Citometria a flusso, Colture cellulari, ELISA, Genomica, Microscopia confocale, Nanoparticle tracking analysis, Polymerase chain reaction (PCR), Sequencing, Ultracentrifuge, Western blot
Patologie: Cancro/Tumori

CROB

Contatti

IRCCS CROB
via Padre Pio 1,
Rionero in Vulture (PZ)

This email address is being protected from spambots. You need JavaScript enabled to view it.

This email address is being protected from spambots. You need JavaScript enabled to view it.
 
This email address is being protected from spambots. You need JavaScript enabled to view it.
 

Patologie

Tumori ematologici, Cancro ai polmoni 
 

Pubblicazioni

  • Trino S., et al. Acute Myeloid Leukemia Cells Functionally Compromise Hematopoietic Stem/Progenitor Cells Inhibiting Normal Hematopoiesis Through the Release of Extracellular Vesicles. Front Oncol. 2022 Mar 16;12:824562. doi: 10.3389/fonc.2022.824562.
  • Laurenzana I., et al. Multiple Myeloma-Derived Extracellular Vesicles Impair Normal Hematopoiesis by Acting on Hematopoietic Stem and Progenitor Cells. Front Med (Lausanne). 2021 Dec 16;8:793040. doi: 10.3389/fmed.2021.793040.
  • Laurenzana I., et al. Analysis of Amount, Size, Protein Phenotype and Molecular Content of Circulating Extracellular Vesicles Identifies New Biomarkers in Multiple Myeloma. Int J Nanomedicine. 2021 May 7;16:3141-3160. doi: 10.2147/IJN.S303391.
  • Trino S. et al. Clinical relevance of extracellular vesicles in hematological neoplasms: from liquid biopsy to cell biopsy. Leukemia. 2021 Mar;35(3):661-678. doi: 10.1038/s41375-020-01104-1.
  • De Luca L., et al. An update on extracellular vesicles in multiple myeloma: a focus on their role in cell-to-cell cross-talk and as potential liquid biopsy biomarkers. Expert Rev Mol Diagn. 2019 Mar;19(3):249-258. doi: 10.1080/14737159.2019.1583103.
  • Laurenzana I., et al. Extracellular Vesicles: A New Prospective in Crosstalk between Microenvironment and Stem Cells in Hematological Malignancies. Stem Cells Int. 2018 May 27;2018:9863194. doi: 10.1155/2018/9863194.
  • Trino S., et al. MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia. Int J Mol Sci. 2018 Feb 3;19(2):460. doi: 10.3390/ijms19020460.
  • Caivano E., et al. Extracellular Vesicles in Hematological Malignancies: From Biology to Therapy. Int J Mol Sci. 2017 Jun 2;18(6):1183. doi: 10.3390/ijms18061183.
  • De Luca L., et al. Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia. Leuk Lymphoma. 2017 Jun;58(6):1424-1432. doi: 10.1080/10428194.2016.1243790.
  • De Luca L., et al. Mesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation? Int J Mol Sci. 2017 May 9;18(5):1022. doi: 10.3390/ijms18051022.
  • Caivano A., et al. MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report. Cell Oncol (Dordr). 2017 Feb;40(1):97-103. doi: 10.1007/s13402-016-0300-x.
  • De Luca L., et al. MiRNAs and piRNAs from bone marrow mesenchymal stem cell extracellular vesicles induce cell survival and inhibit cell differentiation of cord blood hematopoietic stem cells: a new insight in transplantation. Oncotarget. 2016 Feb 9;7(6):6676-92. doi: 10.18632/oncotarget.6791.
  • Caivano A., et al. High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders. Tumour Biol. 2015 Dec;36(12):9739-52. doi: 10.1007/s13277-015-3741-3.

Consorzi di ricerca